Oral Azithromycin for Treatment of Posterior Blepharitis
- 1 October 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cornea
- Vol. 30 (10), 1145-1149
- https://doi.org/10.1097/ico.0b013e318207fc42
Abstract
Purpose: To evaluate the effects of oral azithromycin in patients with posterior blepharitis. Methods: Twenty-six eyes of 13 patients with posterior blepharitis diagnosed by a qualified ophthalmologist were enrolled in this study. Patients were instructed to use oral azithromycin 500 mg per day for 3 days in 3 cycles with 7-day intervals. Subjective clinical outcomes were graded and scored 1 day before and 30 days after the end of the treatment (53 days after initiating the treatment) based on severity scores of: (1) eyelid debris; (2) eyelid telangiectasia; (3) swelling of the eyelid margin; (4) redness of the eyelid margin; and (5) ocular mucus secretion. For the assessment of global efficacy, patients were asked by the investigator to rate the subjective symptoms (eyelid itching, ocular itching, eyelid hyperemia, ocular hyperemia, ocular mucus secretion, photophobia, foreign body sensation, and dry eye sensation) on a scale of 0 (no symptoms) to 5 (severe symptoms). Break-up time, Schirmer I test, corneal fluorescein staining score, and rose bengal staining score were also performed in all patients. Results: All clinical outcomes scoring showed statistically significant improvement after oral azithromycin, except for eyelid swelling. Average subjective symptom grading improved statistically after treatment with oral azithromycin, except for eyelid hyperemia, photophobia, and foreign body sensation. Average tear film break-up time values showed statistically significant improvement after the treatment with oral azithromycin. No statistically significant improvement was observed on average values of Schirmer I test, corneal fluorescein staining score, and rose bengal staining score. Conclusions: The combination of multiple clinical parameters shown in this study supports the clinical efficacy of pulsed oral azithromycin therapy for the management of posterior blepharitis.Keywords
This publication has 40 references indexed in Scilit:
- Blepharitis in the United States 2009: A Survey-based Perspective on Prevalence and TreatmentThe Ocular Surface, 2009
- Blepharitis: current strategies for diagnosis and managementCanadian Journal of Ophthalmology, 2008
- Exposure to a dry environment induces strain-specific responses in miceExperimental Eye Research, 2007
- Research in Dry Eye: Report of the Research Subcommittee of the International Dry Eye WorkShop (2007)The Ocular Surface, 2007
- Changes of symptoms, tear film stability and eosinophilic cationic protein in nasal lavage fluid after re-exposure to a damp office building with a history of floodingIndoor Air, 2006
- Dry Eye Disease: The Scale of the ProblemSurvey of Ophthalmology, 2001
- Changing Concepts in the Diagnosis and Management of BlepharitisCornea, 2000
- Meibomian gland dysfunctionSurvey of Ophthalmology, 1996
- Ocular Surface Changes and Discomfort in Patients With Meibomian Gland DysfunctionAmerican Journal of Ophthalmology, 1995
- Classification of Chronic BlepharitisOphthalmology, 1982